This webinar will help you understand the process, requirements, quality and safety considerations for demonstrating biosimilarity to a Reference Product. You will learn about what type and how much clinical data are needed to support a showing of biosimilarity.
Making Sense of FDA’s (proposed) Rules for the Development and Approval of Biosimilars
30 May 2012, Palo Alto, United States
Introduction
Venue
2600 E. Bayshore Road, Palo Alto, 94303, United States
Useful links
Organised by
ComplianceOnline
Contact information
Referral
2600 E. Bayshore Road, Palo Alto, 94303, United States of America
1-650-620-3915
Contact us by email
2600 E. Bayshore Road, Palo Alto, 94303, United States of America
1-650-620-3915
Contact us by email
Search
Advertisement
Spotlight
Explore
Membership
